SCHEDULE OF RECONCILIATION OF INCOME TAX EXPENSES (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Income Tax Disclosure [Abstract] | |||
| Income before income tax expenses | $ 3,870,585 | $ 3,985,403 | $ 8,721,068 |
| Computed income tax expenses with statutory tax rate | 967,647 | 997,115 | 2,180,267 |
| Differential income tax rates applicable to certain entities | (1,152,726) | (341,814) | (1,080,231) |
| Additional deduction for research and development expenses | (128,854) | (188,840) | (509,024) |
| Tax-exempted loss (income) | 205,790 | (534,074) | (1,011,906) |
| Tax effect of permanent difference | 56,880 | (2,335) | 45,625 |
| Effect of temporary differences | 90,895 | ||
| Changes in valuation allowance | 69,803 | 235,538 | 414,681 |
| Current income tax expenses (benefits) | $ 18,540 | $ 165,590 | $ 130,307 |
| X | ||||||||||
- Definition Income tax reconciliation non deductible expense research and development expenses. No definition available.
|
| X | ||||||||||
- Definition Income tax reconciliation nondeductible expense taxexempted income. No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|